Effect of lipopolysaccharide on inflammation and insulin action in human muscle.

Accumulating evidence from animal studies suggest that chronic elevation of circulating intestinal-generated lipopolysaccharide (LPS) (i.e., metabolic endotoxemia) could play a role in the pathogenesis of insulin resistance. However, the effect of LPS in human muscle is unclear. Moreover, it is unkn...

Full description

Bibliographic Details
Main Authors: Hanyu Liang, Sophie E Hussey, Alicia Sanchez-Avila, Puntip Tantiwong, Nicolas Musi
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3660322?pdf=render
id doaj-f9270458eda64a3fac07cea8e766018c
record_format Article
spelling doaj-f9270458eda64a3fac07cea8e766018c2020-11-25T02:56:07ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0185e6398310.1371/journal.pone.0063983Effect of lipopolysaccharide on inflammation and insulin action in human muscle.Hanyu LiangSophie E HusseyAlicia Sanchez-AvilaPuntip TantiwongNicolas MusiAccumulating evidence from animal studies suggest that chronic elevation of circulating intestinal-generated lipopolysaccharide (LPS) (i.e., metabolic endotoxemia) could play a role in the pathogenesis of insulin resistance. However, the effect of LPS in human muscle is unclear. Moreover, it is unknown whether blockade/down regulation of toll-like receptor (TLR)4 can prevent the effect of LPS on insulin action and glucose metabolism in human muscle cells. In the present study we compared plasma LPS concentration in insulin resistant [obese non-diabetic and obese type 2 diabetic (T2DM)] subjects versus lean individuals. In addition, we employed a primary human skeletal muscle cell culture system to investigate the effect of LPS on glucose metabolism and whether these effects are mediated via TLR4. Obese non-diabetic and T2DM subjects had significantly elevated plasma LPS and LPS binding protein (LBP) concentrations. Plasma LPS (r = -0.46, P = 0.005) and LBP (r = -0.49, P = 0.005) concentrations negatively correlated with muscle insulin sensitivity (M). In human myotubes, LPS increased JNK phosphorylation and MCP-1 and IL-6 gene expression. This inflammatory response led to reduced insulin-stimulated IRS-1, Akt and AS160 phosphorylation and impaired glucose transport. Both pharmacologic blockade of TLR4 with TAK-242, and TLR4 gene silencing, suppressed the inflammatory response and insulin resistance caused by LPS in human muscle cells. Taken together, these findings suggest that elevations in plasma LPS concentration found in obese and T2DM subjects could play a role in the pathogenesis of insulin resistance and that antagonists of TLR4 may improve insulin action in these individuals.http://europepmc.org/articles/PMC3660322?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Hanyu Liang
Sophie E Hussey
Alicia Sanchez-Avila
Puntip Tantiwong
Nicolas Musi
spellingShingle Hanyu Liang
Sophie E Hussey
Alicia Sanchez-Avila
Puntip Tantiwong
Nicolas Musi
Effect of lipopolysaccharide on inflammation and insulin action in human muscle.
PLoS ONE
author_facet Hanyu Liang
Sophie E Hussey
Alicia Sanchez-Avila
Puntip Tantiwong
Nicolas Musi
author_sort Hanyu Liang
title Effect of lipopolysaccharide on inflammation and insulin action in human muscle.
title_short Effect of lipopolysaccharide on inflammation and insulin action in human muscle.
title_full Effect of lipopolysaccharide on inflammation and insulin action in human muscle.
title_fullStr Effect of lipopolysaccharide on inflammation and insulin action in human muscle.
title_full_unstemmed Effect of lipopolysaccharide on inflammation and insulin action in human muscle.
title_sort effect of lipopolysaccharide on inflammation and insulin action in human muscle.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2013-01-01
description Accumulating evidence from animal studies suggest that chronic elevation of circulating intestinal-generated lipopolysaccharide (LPS) (i.e., metabolic endotoxemia) could play a role in the pathogenesis of insulin resistance. However, the effect of LPS in human muscle is unclear. Moreover, it is unknown whether blockade/down regulation of toll-like receptor (TLR)4 can prevent the effect of LPS on insulin action and glucose metabolism in human muscle cells. In the present study we compared plasma LPS concentration in insulin resistant [obese non-diabetic and obese type 2 diabetic (T2DM)] subjects versus lean individuals. In addition, we employed a primary human skeletal muscle cell culture system to investigate the effect of LPS on glucose metabolism and whether these effects are mediated via TLR4. Obese non-diabetic and T2DM subjects had significantly elevated plasma LPS and LPS binding protein (LBP) concentrations. Plasma LPS (r = -0.46, P = 0.005) and LBP (r = -0.49, P = 0.005) concentrations negatively correlated with muscle insulin sensitivity (M). In human myotubes, LPS increased JNK phosphorylation and MCP-1 and IL-6 gene expression. This inflammatory response led to reduced insulin-stimulated IRS-1, Akt and AS160 phosphorylation and impaired glucose transport. Both pharmacologic blockade of TLR4 with TAK-242, and TLR4 gene silencing, suppressed the inflammatory response and insulin resistance caused by LPS in human muscle cells. Taken together, these findings suggest that elevations in plasma LPS concentration found in obese and T2DM subjects could play a role in the pathogenesis of insulin resistance and that antagonists of TLR4 may improve insulin action in these individuals.
url http://europepmc.org/articles/PMC3660322?pdf=render
work_keys_str_mv AT hanyuliang effectoflipopolysaccharideoninflammationandinsulinactioninhumanmuscle
AT sophieehussey effectoflipopolysaccharideoninflammationandinsulinactioninhumanmuscle
AT aliciasanchezavila effectoflipopolysaccharideoninflammationandinsulinactioninhumanmuscle
AT puntiptantiwong effectoflipopolysaccharideoninflammationandinsulinactioninhumanmuscle
AT nicolasmusi effectoflipopolysaccharideoninflammationandinsulinactioninhumanmuscle
_version_ 1724714123924602880